Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardioangiologica 2016 August;64(4) > Minerva Cardioangiologica 2016 August;64(4):419-41

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as
Share

 

REVIEWS  NEW BIORESORBABLE TECHNOLOGY IN INTERVENTIONAL CARDIOLOGY 

Minerva Cardioangiologica 2016 August;64(4):419-41

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

The BVS concept. From the chemical structure to the vascular biology: the bases for a change in interventional cardiology

Giuseppe TARANTINI 1, Giulia MASIERO 1, Juan F. GRANADA 2, Richard J. RAPOZA 3

1 Department of Cardiac, Vascular and Thoracic Sciences, University of Padua, Padua, Italy; 2 Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, Orangeburg, New York, NY, USA; 3 Abbott Vascular, Santa Clara, CA, USA


PDF


Bioresorbable vascular scaffolds (BVS), the fourth generation of percutaneous coronary intervention (PCI), aim to improve the long-term outcomes of PCI facilitating the restoration of the physiology of the treated vessels when the scaffold dismantling process is completed. In this paper we will review all the technical aspects as well as the potential clinical indications of this technology.

top of page